LNSR Q1 2022 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$9M+32.6% YoY

Gross Profit

$5M50.2% margin

Operating Income

-$7M-71.6% margin

Net Income

-$7M-71.5% margin

EPS (Diluted)

$-0.67

QoQ Revenue Growth

-16.8%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$60M

Total Liabilities

$10M

Stockholders' Equity

$50M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$7M	+32.6%
Gross Profit	$5M	$4M	+20.5%
Operating Income	-$7M	-$5M	-28.5%
Net Income	-$7M	-$5M	-28.8%

Revenue Segments

Product

$7M88%

Service

$972,00012%

Geographic Segments

UNITED STATES

$4M50%

Europe

$2M20%

KOREA, REPUBLIC OF

$1M18%

Asia Excluding South Korea

$780,00010%

Other Geographical Region

$138,0002%